Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies.

Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006-2010. PLoS One (2016) 1.39

Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice. Anesth Analg (2016) 0.90

Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa). Anemia (2015) 0.79

Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia. Anemia (2012) 0.76

Management of priapism in adult men. Int Surg (2015) 0.75

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA (2005) 6.49

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood (2005) 3.98

Frequency of sickling disorders in U.S. blacks. N Engl J Med (1973) 2.74

Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A (2005) 2.25

Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet (2003) 2.15

PRIAPISM: REPORT OF CASES AND A CLINICAL STUDY OF THE LITERATURE WITH REFERENCE TO ITS PATHOGENESIS AND SURGICAL TREATMENT. Ann Surg (1914) 2.02

Hemolysis-associated priapism in sickle cell disease. Blood (2005) 1.86

Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest (2008) 1.66

Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology (2006) 1.27

RhoA-mediated Ca2+ sensitization in erectile function. J Biol Chem (2002) 1.25

Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB J (2009) 1.15

Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. Eur Urol (2006) 1.13

Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation. Mol Pharmacol (2005) 1.12

Medicine. Sickle cell disease at 100 years. Science (2010) 1.05

Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med (2008) 1.03

Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet (1985) 1.02

Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Haematol (2002) 1.01

Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach. Urology (2009) 1.01

Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology (1996) 0.99

Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. Int J Impot Res (2002) 0.95

Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice. Urology (2010) 0.95

Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. J Sex Med (2006) 0.84

Nocturnal oxygen desaturation in patients with sickle cell anemia. JAMA (1983) 0.84

Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion. J Urol (2010) 0.84

Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J Neurosci (2006) 1.48

FK506 and erectile function preservation in the cavernous nerve injury model: optimal dosing and timing. J Sex Med (2008) 0.81

Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery. J Sex Med (2013) 0.79

Chronology of erectile function in patients with early functional erections following radical prostatectomy. J Sex Med (2009) 0.78

Words of wisdom. Re: Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion. Eur Urol (2014) 0.75

[Current treatment and management of the acute phase of Peyronies's disease]. Arch Esp Urol (2009) 0.75

The adverse impact of COVID-19 on men's health. Curr Opin Urol (2022) 0.75